Apo2L/TRAIL, a new cancer drug, has shown activity in treating advanced cancers with minimal side effects. The agent selectively induces programmed cell death in cancer cells while sparing normal cells, offering hope for targeted treatment options.
Researchers found a new predictor of disease for overweight men using PSA density calculation, helping to accurately diagnose prostate cancer in this high-risk group. The study analyzed 647 men with elevated PSA levels and identified a lower PSAD calculation needed for accurate diagnosis, beating prior predictors.
Children born between 34-36 weeks gestation are at a significantly higher risk of developing hyperactivity disorder. Low birthweight babies, especially those weighing 1500-2499g, are also at increased risk. Risk factors include single parenthood, social and economic deprivation, and young age at parenthood.
Researchers have developed a new treatment option that breaks Leukemia's resistance to chemotherapy and radiation therapy by targeting specific cells with alpha particles. This approach increases the dose to leukemia cells, causing cell kill while sparing non-target tissues from detrimental radiation effects.
Walter Wolf, distinguished professor of pharmaceutical sciences at USC, received the award for his groundbreaking work in pharmacokinetic imaging and radiopharmaceuticals. His research focuses on noninvasive studies of drug biodistribution and targeting using nuclear medicine imaging and magnetic resonance spectroscopy.
Australian researchers found that caffeine consumption increases agreement with persuasive arguments by boosting systematic processing of the message, leading to better argument recall. This effect could have applied implications in various daily interactions, such as listening to advertisements or attending business meetings.
Researchers have developed a non-invasive method to detect atherosclerosis by measuring coronary blood flow, allowing for early detection and treatment of high-risk patients. The study found that elevated levels of interleukin-6 are a major determinant of coronary endothelial dysfunction in individuals with hypertension.
Research reveals genetic variants in genes involved in anthracyclines' metabolism increase risk of congestive heart failure (CHF) in childhood cancer survivors. The study suggests personalized treatment plans may be developed using gene classification to reduce toxic side effects.
A survey of 228 women found that 33% initially misunderstood the results and 24% became more anxious after learning their status. However, 39% reported a decrease in anxiety, highlighting the need for clear communication about clinical trial results.
A recent study published by Memorial Sloan Kettering Cancer Center has shown that a targeted therapy called sunitinib is effective in treating patients with advanced kidney cancer. The study found that sunitinib significantly improved progression-free survival and tumor shrinkage compared to standard treatment with interferon-alpha.
Researchers have identified a protein associated with severe preeclampsia, which is a major cause of maternal and fetal mortality worldwide. Endoglin acts together with sFlt1 to amplify vascular damage, leading to high blood pressure, edema, and other symptoms.
A five-year study confirms Gleevec's effectiveness in treating Gastrointestinal Stromal Tumor (GIST), with 84% of participants showing clinical improvement. The treatment has durable benefits, with two patients experiencing complete remission, despite some developing resistance.
Researchers found that when treatment was restarted after a chemotherapy holiday, roughly three-quarters of study subjects responded again or experienced stabilized PSA levels. The median duration of the first chemotherapy holiday was 16 weeks, providing a clinically meaningful break for most patients.
Participating in a daily yoga program during breast cancer treatment has been shown to improve physical function, general health, and social functioning among women. The study also found significant reductions in sleep-related daytime dysfunction and fatigue, but no impact on depression or anxiety.
A new study reveals a growing osteoporosis crisis in Latin America, with higher prevalence rates than expected. The study's findings highlight the need for increased attention and funding from governments to address this growing health issue. In contrast, North American diagnosis and treatment of osteoporosis are influenced by socioeco...
Researchers discovered that an endogenous peptide called LL-37 plays a critical role in preventing urinary tract infections. Boosting LL-37 levels may provide a new way to prevent UTIs and offer a defense against the infection.
Gambhir, a renowned Stanford University scientist, is recognized for his extensive work in molecular imaging and basic science of using radioactive tracers. He has developed numerous methods for imaging gene/cell therapy and protein-protein interactions in living subjects.
A phase-2 clinical trial found that Pfizer's oral drug, sunitinib malate, showed activity similar to other approved agents for non-small cell lung cancer, resulting in six confirmed partial responses and disease stabilization in 27 patients. The study also explored the effectiveness and safety of a continuous dosing strategy.
A study of over 2000 blood samples found that individuals with unfavourable blood fat levels were more likely to develop rheumatoid arthritis. Total cholesterol and triglyceride levels were higher in those who developed the disease, indicating an increased risk of ischaemic heart disease.
Rates of hip bone loss increase with age among white and non-white men, particularly those over 75. Osteoporosis in men results from declining estrogen levels, leading to brittle bones prone to fracture. The study predicts a 56% increase in male osteoporotic fractures and associated costs by 2025.
A double-blind randomized controlled trial found that two breathing techniques can reduce reliance on medication and improve quality of life for adults with mild asthma. Participants experienced an 86% decrease in reliever medication use over a period of eight months.
A new combination therapy after surgery has improved survival rates for pancreatic cancer patients by 50%, increasing median survival from 16.9 to 20.6 months. The study found significant benefits for patients with pancreatic head adenocarcinoma, a type of cancer that affects the pancreas.
The 2nd IOF Women Leaders Roundtable emphasizes the need for global awareness and action on osteoporosis. The participants urge individuals to engage in bone-friendly lifestyles and healthcare professionals to improve their knowledge about osteoporosis, while governments are encouraged to recognize it as a health priority.
A recent study found that osteoporosis is widely underdiagnosed and undertreated, with many patients stopping their prescribed medication prematurely. Low trauma fractures are often an indication of osteoporosis, but patients may not receive adequate screening or education on managing the condition.
The study found that black patients had a significantly lower response rate to chemotherapy treatments compared to white patients. However, they also showed less severe toxicity and longer survival rates. Genetic differences in metabolism of chemotherapy drugs may play a role in these racial differences.
Researchers found that injecting mice with gene therapy containing myostatin propeptide accelerated muscle regeneration and reduced fibrosis after injury. This approach could significantly reduce recovery time for athletes and lead to more complete functional recovery.
A new study by Dr. Ramalingam found that adding the drug vorinostat to standard chemotherapy improved outcomes for patients with advanced non-small cell lung cancer, with partial responses in 11 patients and disease stabilization in 7 more. The recommended dose of 400mg daily for two weeks was well-tolerated.
A study found that ramelteon, a new sleep medication, does not instigate the same cognitive effects as other commonly prescribed sleep aids. The research suggests that ramelteon is unlikely to promote benzodiazepine-type dependence and may be a safer alternative for treating insomnia.
Researchers have found a promising new treatment for children with metastatic Gastrointestinal Stromal Tumor (GIST) that is resistant to imatinib. The therapy, sunitinib, has shown significant decreases in tumor-related activity and complete remission in some patients.
Research suggests that infant bone growth and maternal vitamin D levels during pregnancy have a significant impact on future fracture risk. Children born to mothers with lower vitamin D levels tend to have weaker bones, while higher levels may improve bone density.
A study found that patients with advanced liver, gallbladder, and bile duct cancers who developed a skin rash while treated with lapatinib lived for an average of 10 months, compared to five months for those without the rash. The treatment was well-tolerated, with two patients experiencing partial responses to treatment.
A new time-of-flight PET scanner with LYSO detector crystals improves diagnostic accuracy and reduces variability in patient images. This technology enables more accurate detection of small lesions and better lesion characterization, leading to improved cancer diagnosis and treatment.
A new three-drug regimen combining Taxotere with standard chemotherapy reduces mortality by nearly 30 percent in patients with squamous cell carcinoma of the head and neck. The study, conducted at Dana-Farber Cancer Institute, showed improved survival rates with this treatment approach.
A study of 31 young men in inner London found that engaging in unhealthy masculine behaviors can harm health, while positive behaviors like sport can have a positive impact. The research calls for greater understanding of attitudes to masculinity in health promotion.
Studies have shown that glycerrhetinic acid and glycerrhizic acid, found in liquorice, preferentially accumulate in the liver and can target tumors effectively. This could lead to improved treatment outcomes with reduced toxic effects on other parts of the body.
A new model predicts osteoporosis risk by integrating age, height, weight, and other factors, identifying susceptible individuals for targeted treatment. Researchers also found that obesity accelerates bone loss, contradicting prior assumptions, and that certain medications like SSRIs may increase fracture risk.